Found 1191 matching trials
Efficacy and Safety of Lobaplatin and Carboplatin as Neoadjuvant Therapy in HER-2 Positive Breast Cancer PHASE4 The aim of this study was to evaluate the efficacy, safety and tolerability...
Show More Location
Breast Cancer Center Shandong Cancer Hospital and Institute Shandong First Medical University and Shandong Academy of Medical Sciences
Learn More & Join Trial
Immunotherapy Plus Chemotherapy vs. Chemoradiotherapy for Thoracic Squamous Esophageal Carcinoma PHASE2 The investigators conducted a phase II, prospective, two-arm clinical study...
Show More Location
Fujian Medical University Union Hospital
Learn More & Join Trial
Mathematical Modeling to Predict Response to Neoadjuvant Chemotherapy in Breast Cancer N/A This is a feasibility study evaluating the use of a mathematical model to p...
Show More Location
University of New Mexico Comprehensive Cancer Center
Learn More & Join Trial
Efficacy and Safety of Serplulimab Combined With Chemotherapy as Neoadjuvant Treatment for Locally Advanced Gastric Cancer or Adenocarcinoma of Esophagogastric Junction PHASE2 This is a multicenter, double-blind, randomized, phase 2 trial to investiga...
Show More Location
The fourth hospital of Hebei Medical University
Learn More & Join Trial
A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Head and Neck Cancer PHASE1 The purpose of this study is to determine safety and preliminary efficacy o...
Show More Location
University of California at San Diego Moores Cancer Center
Learn More & Join Trial
Surgery vs. Radical Chemoradiotherapy for Esophageal SCC After Neoadjuvant Immunochemotherapy PHASE3 This is a Phase III, multicenter, open-label, randomized controlled trial. ...
Show More Location
Henan Cancer Hospital
Learn More & Join Trial
Pancreatic Adenocarcinoma Neoadjuvant Chemotherapy Before Surgery PHASE2 This is a single-arm, single-center feasibility trial of patients with bord...
Show More Location
Juravinski Hospital
Learn More & Join Trial
NeoOPTIMIZE: Early Switching of mFOLFIRINOX or Gemcitabine/Nab-Paclitaxel Before Surgery for the Treatment of Resectable, Borderline Resectable, or Locally-Advanced Unresectable Pancreatic Cancer PHASE2 This phase II trial evaluates whether early switching from modified fluorou...
Show More Status
Active Not Recruiting
Location
OHSU Knight Cancer Institute
Learn More & Join Trial
Penpulimab Combined With Chemotherapy for Neoadjuvant and Adjuvant Therapy in Patients With Resectable HNSCC PHASE2 This study aims to observe and explore the efficacy and safety of Penpulima...
Show More Location
Shanghai Ninth People's Hostipal, Shanghai Jiao Tong University School of Medicine
Learn More & Join Trial
Trial of Neoadjuvant Chemotherapy With S1 Plus Paclitaxel-albumin on Pancreatic Cancer PHASE2 The study is to evaluate the R0 resection rate of patients with unresectabl...
Show More Location
Zhejiang procincial people's hospital
Learn More & Join Trial